Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-18
2006-04-18
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S340000, C514S254020
Reexamination Certificate
active
07030142
ABSTRACT:
The invention relates to novel methods using, and pharmaceutical compositions comprising, ziprasidone metabolites. The methods and compositions of the invention are suitable for the treatment of neuroleptic and related disorders. The invention further encompasses methods of preparing ziprasidone sulfoxide and ziprasidone sulfone.
REFERENCES:
patent: 4411901 (1983-10-01), Temple, Jr. et al.
patent: 4590196 (1986-05-01), Smith et al.
patent: 4831031 (1989-05-01), Lowe, III et al.
patent: 5312925 (1994-05-01), Allen et al.
patent: EP 0 790 236 (1997-08-01), None
patent: WO 93/16073 (1993-08-01), None
Geodon (Ziprasidone HCI), Pfizer Inc.
Prakash et al. Metabolism and Excretion of a New Antipsychotic Drug, Ziprasidone, in Humans, Drug Metabolism and Disposition, vol. 25, No. 7, 863-871 (1997).
Davis et al., Ziprasidone, abstract, 1997: 593623 CAPLUS, 1997.
Parkash et al., Metabolism and Excretion of a New Antipsychotic Drug, ziprasidone, in humans: Drug Metabolism and Disposition vol. 25, No. 7, 1997.
J.P. Yevich et al., “Synthesis and Biological Evaluation of 1-(1,2-Benzisothiazol-3-YL)-and (1,2-Benzisoxazol-3-YL) Piperazine Derivatives as Potential Antipsychotic Agents,”Journal of Medicinal Chemistry, U.S. American Chemical Society, vol. 29, No. 3, Mar. 1, 1986, pp. 359-369.
Chandra Prakash, et al, “Metabolism and Excretion of the Novel Antipsychotic Drug Ziprasidone in Rats After Oral Administration of a Mixture of14C- And3H-Labeled Ziprasidone”, Drug Metabolism and Disposition, vol. 25, pp. 206-218.
Chandra Prakash, et al., “Metabolism and Excretion of a New Antipsychotic Drug, Ziprasidone in Humans”, Drug Metabolism and Disposition, vol. 25, pp. 863-871.
Barberich Timothy J.
Rubin Paul D.
Yelle William E.
Jones Day
Padmanabhan Sreeni
Sepracor Inc.
Sharareh Shahnam
LandOfFree
Methods for the treatment of neuroleptic and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of neuroleptic and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of neuroleptic and related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3600417